Achieving remission of proteinuria in childhood CKD.
Piero RuggenentiPaolo CravediAntonietta ChiancaMariaRosa CarusoGuiseppe RemuzziPublished in: Pediatric nephrology (Berlin, Germany) (2016)
Combination therapy with maximum approved doses of ACE inhibitors and ARBs is a safe strategy which may achieve proteinuria remission with kidney function stabilization or even improvement in a substantial proportion of children with proteinuric nephropathies.